Brain Tumor Treatments: Texas
Sponsored By
Cleveland ClinicBrain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Texas
Please scroll down to see the matching trials.

  (0.8169)   Brain Tumor Treatments: Texas
  (0.7967)   RSR-13
  (0.7967)   Virtualtrials Newsletter
  (0.7967)   Noteworthy Treatments For Brain Tumors
  (0.7967)   RSR-13
  (0.7967)   RSR-13
  (0.7967)   Virtualtrials Newsletter
  (0.7742)   Brain Tumor Treatments: Gene Therapy
  (0.7742)   Brain Tumor Dictionary
  (0.7742)   Treatments
  (0.7742)   Treatments
  (0.7742)   BORON NEUTRON CAPTURE THERAPY (BNCT)
  (0.7742)   Chemosensitivity Testing
  (0.7742)   Doctor / Hospital Address Book
  (0.7742)   Brain Tumor Activism
  (0.7742)   Letter Writing Wizard
  (0.7742)   Brain Tumor Activism
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Temozolomide Update
  (0.7742)   Untitled Document
  (0.7742)   BrainTumor Chat: Dr. Friedman
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Noteworthy Treatments For Brain Tumors

Sorry - There were no pages found that contain that search phrase.



  Treatment Location Last Updated
Details Gliogene: An International Brain Tumor Study Houston, TX 07/24/2008
Details A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma Houston, TX USA 07/24/2008
Details A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer Houston, TX USA 07/24/2008
Details A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer San Antonio, TX USA 07/24/2008
Details A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Houston, TX USA 07/03/2008
Details A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme San Antonio, TX USA 07/03/2008
Details A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma Dallas, TX USA 06/28/2008
Details Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma Houston, TX USA 05/28/2008
Details Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme Houston, TX USA 05/28/2008
Details Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme Houston , TX 04/27/2008
Details A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme Houston, TX USA 04/16/2008
Details Phase I/II Study of Temozolomide and Intrathecal DepoCyt in Patients with Neoplastic Meningitis Houston, TX USA 04/16/2008
Details A Phase II Study of Rituximab and Temozolomide in Recurrent Primary CNS Lymphoma Houston, TX USA 04/16/2008
Details Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma Houston, TX USA 04/15/2008
Details Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma San Antonio, TX USA 04/15/2008
Details Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Houston, TX USA 04/15/2008
Details Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma San Antonio, TX USA 04/15/2008
Details Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Houston, TX USA 04/15/2008
Details Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas Houston, TX USA 04/15/2008
Details Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas San Antonio, TX USA 04/15/2008
Details Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients with Recurrent Malignant Glioma Houston, TX USA 04/15/2008
Details Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme Houston, TX USA 04/15/2008
Details A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma Houston, TX USA 04/15/2008
Details A Phase I Dose-Finding and Pharmacokinetic Study of Intravenous RTA 744 Injection in Patients with Recurrent or Refractory Glioma, with or without Concurrent Treatment with Enzyme-Inducing Anticonvulsant Drug Therapy. Houston, TX USA 04/15/2008
Details Phase 2, 2-part, multicenter, open-label study to evaluate the safety, tolerability, and efficacy of CT-322 (Angioceptâ„¢) monotherapy and combination therapy with irinotecan in patients with recurrent glioblastoma multiforme Houston, TX USA 04/15/2008
Details Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma Houston, TX USA 04/15/2008
Details A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas Houston, TX USA 04/15/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Houston, TX USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Temple, TX USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Lubbock, TX USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Galveston, TX USA 04/11/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Houston, TX USA 04/11/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Galveston, TX USA 04/11/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme San Antonio, TX USA 04/11/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Lubbock, TX USA 04/11/2008
Details Gliogene: Brain Tumor Linkage Study Houston, Tx USA 01/17/2008
Details NABTC 04-01: Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma Houston, TX USA 10/03/2007
Details NABTC 04-01: Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma San Antonio, TX USA 10/03/2007
Details NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma Houston, TX USA 10/03/2007
Details NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma San Antonio, TX USA 10/03/2007
Details Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor San Antonio, TX USA 08/18/2007
Details Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme Houston, TX USA 08/18/2007
Details Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma Houston, TX USA 08/04/2007
Details A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors Dallas, TX USA 06/04/2007
Details Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas Houston, TX USA 04/29/2007
Details Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas Fort Worth, TX USA 04/29/2007
Details Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas Lubbock, TX USA 04/29/2007
Details Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas Dallas, TX USA 04/29/2007
Details Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas San Antonio, TX USA 04/29/2007
Details Phase I/II Pazopanib Plus Lapatinib for Relapsed Malignant Glioma Houston, TX USA 04/15/2007
Details Combination Therapy With Thalidomide and CPT-11 in Patients With Recurrent Anaplastic Gliomas or Glioblastoma Multiforme Houston , TX 04/15/2007
Details RTA 744 in Treating Patients With Recurrent or Refractory Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Glioblastoma Multiforme, or Gliosarcoma Dallas, TX USA 11/21/2006
Details Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patients with Plexiform Neurofibromas Dallas, TX USA 11/21/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Temple, TX USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Austin, TX USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Lubbock, TX USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) San Antonio, TX USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Houston, TX USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Dallas, TX USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Amarillo, TX USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) San Antonio, TX USA 10/12/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Fort Worth, TX USA 05/30/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Amarillo, TX USA 05/30/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Corpus Christi, TX USA 05/30/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Dallas, TX USA 05/30/2006
Details Phase II Study of Rituximab, Temozolomide, and Methylprednisolone in Patients With Recurrent Primary CNS Non-Hodgkin`s Lymphoma San Antonio, TX USA 05/27/2006
Details Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Houston, TX USA 05/27/2006
Details PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas Houston, TX USA 05/04/2006
Details PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas San Antonio, TX USA 05/04/2006
Details Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Houston, TX USA 05/02/2006
Details Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors Houston, TX USA 05/01/2006
Details Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma Houston, TX USA 11/27/2005
Details Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas Houston, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Houston, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Temple, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Temple, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Austin, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Fort Worth, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Lubbock, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma San Antonio, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Houston, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Dallas, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Lackland Air Force Base, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Dallas, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Amarillo, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma San Antonio, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Galveston, TX USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma San Antonio, TX USA 11/27/2005
Details A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma Houston, TX USA 11/27/2005
Details Phase 2 Trial of Salvage Chemotherapy with Temozolomide in Combination with Topotecan for Primary CNS Lymphoma. San Antonio, TX USA 11/27/2005
Details Longitudinal Neuropsychologic Evaluation And Strategic Educational Interventions. Houston, TX USA 11/27/2005
Details Rehabilitation For Brain Tumor Patients. Houston, TX USA 11/27/2005
Details Pilot Study of Systemic and Intrathecal Chemotherapy Followed by Conformal Radiation for Infants with Brain Tumors Houston, TX USA 11/27/2005
Details Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme Houston, TX USA 11/27/2005
Details A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas Houston, TX USA 11/27/2005
Details A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas San Antonio, TX USA 11/27/2005
Details Intra-arterial carboplatin for supratentorial brain tumors Fort Worth, TX USA 11/26/2005
Details Melatonin to correct the sleep fragmentation induced by corticosteroids Houston, TX USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Houston, TX USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Austin, TX USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Fort Worth, TX USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Lubbock, TX USA 11/26/2005
Details